KRTL Holding Group Inc. (OTC: KRTL) ("KRTL" or the "Company") today announced a category spotlight on anti-allergy and respiratory health products, reinforcing its strategic intent to address rising global demand for accessible, effective treatments across both developed and emerging healthcare markets. The global allergy treatment market is projected to reach USD 35.8 billion by 2028, according to The Insight Partners, driven by increased urban exposure to pollutants, climate-linked allergen...

KRTL Holding Group Inc. (OTC: KRTL) ("KRTL" or the "Company") is proud to spotlight CaviGuard, an innovative dental care system developed in Bolivia and manufactured by its majority-owned subsidiary, Industria Químico-Farmacéutica SIGMA Corp. The system utilizes a non-invasive protocol that avoids drilling and anesthesia, offering a practical alternative to conventional cavity treatment. Now expanding beyond Bolivia, CaviGuard is being introduced in Brazil and the United States as part of...

KRTL Holding Group Inc. (OTC: KRTL) ("KRTL" or the "Company") proudly congratulates its majority-owned subsidiary, Industria Químico-Farmacéutica SIGMA Corp., for receiving the PATUJÚ Award from Bolivia’s Ministry of Justice and Institutional Transparency in collaboration with the Chamber of Industry, Commerce, and Services of Cochabamba (ICAM). This prestigious recognition was presented to SIGMA under the category of Implementation of Regulatory Compliance Components, highlighting its...